Status:

COMPLETED

Comparative Effects of Fish Oil Supplementation and a Montelukast on EIB and Airway Inflammation in Asthma

Lead Sponsor:

Indiana University

Conditions:

Asthma

Eligibility:

All Genders

18-40 years

Phase:

PHASE1

Brief Summary

Combining fish oil supplementation and Montelukast \[a commonly used cyst LT1 receptor antagonist to treat exercise-induced bronchoconstriction (EIB)\] will provide a greater antiinflammatory effect a...

Detailed Description

The aim of this study is to extend previous published findings that fish oil supplementation represents a beneficial treatment on exercise-induced bronchoconstriction (EIB). An important question is h...

Eligibility Criteria

Inclusion

  • Demonstrate a fall in post-exercise FEV1 of \> 10% after dry air exercise challenge for the diagnosis of EIB and
  • \> 12% increase in FEV1 from the baseline value after the administration of a β2-agonist. However, if the bronchodilator response is \< 12% increase in FEV1 from the baseline value then asthmatic subjects with EIB must further demonstrate
  • A \< 16.0 mg.ml-1 concentration of methacholine causing a 20% decrease in FEV1 (PC20)

Exclusion

  • Subjects will be excluded if they are pregnant
  • Have a history of hyperlipidemia, hypertension, diabetes, bleeding disorders, delayed clotting time
  • Taking aspirin medication and have a resting FEV1 less than 65% predicted.
  • A complete blood count and urinary pregnancy tests will be conducted at the beginning of the study and subjects with a hematocrit \< 35 will be excluded from participation in the study.
  • In addition, subjects will also be excluded if they have a history of taking n-3 PUFA supplements or supplements with antioxidants above the levels recommended for Adequate Intake, or regularly consume more than one fish meal per week.

Key Trial Info

Start Date :

September 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2009

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00676468

Start Date

September 1 2008

End Date

April 1 2009

Last Update

October 9 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Indiana University

Bloomington, Indiana, United States, 47405